The largest database of trusted experimental protocols

Hs00900055 m1

Manufactured by Thermo Fisher Scientific
Sourced in United States

The Hs00900055_m1 is a TaqMan Gene Expression Assay produced by Thermo Fisher Scientific. It is a pre-designed and validated assay used for the quantification of a specific gene target. The assay includes a fluorogenic probe and primer set designed to detect and measure the expression level of the target gene.

Automatically generated - may contain errors

6 protocols using hs00900055 m1

1

Quantitative RNA Expression Analysis in Tumor Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was extracted from tumor cells using the RNeasy Mini Kit (Qiagen, Valencia, CA, USA) and from frozen tumor tissues using Sepasol-RNA I Super (Nacalai Tesque, Kyoto, Japan) according to the manufacturer’s protocol and subsequently purified with the DNA-free™ DNA Removal kit (Ambion, Austin, TX, USA). The quality of the total RNA was verified using the 260/280 nm ratio and a NanoDrop 2000 (Thermo Fisher Scientific, Wilmington, DE, USA). qRT-PCR was performed using a TaqMan system on an Applied Biosystems StepOne™ machine (Carlsbad, CA, USA) according to the manufacturer’s instruction. Target-specific primers and probes for human GRM1 (Hs00168250_m1), 53BP1 (Hs00996827_m1), CDKN1A (Hs00355782_m1), IL-6 (Hs00174131_m1), CXCL8 (Hs00174103_m1), TNF-α (Hs00174128_m1), VEGFA (Hs00900055_m1), MET (Hs01565584_m1) and 18S ribosomal RNA (18S rRNA, Hs99999901_s1) were purchased from Applied Biosystems. The normalized Ct value of each gene was obtained by subtracting the Ct value for 18S rRNA.
+ Open protocol
+ Expand
2

Quantifying VEGFR1, VEGF-A, and miR-520a-3p

Check if the same lab product or an alternative is used in the 5 most similar protocols
TaqMan qPCR analysis of VEGFR1, VEGF-A and has-miR-520a-3p expression were carried out using preformulated assays (Hs01052961_m1, Hs00176573_m1, Hs00900055_m1 and Hs03294648_pri; Applied Biosystems) with an Applied Biosystems 7900HT real-time PCR system set for an ΔΔCT quantitation protocol. The TaqMan assay for FLT1P1 was custom-designed based on regions of differences in the FLT1P1 transcripts and VEGFR1 mRNA sequence (Supplementary Table S1). Oligonucleotide primers and a dual-labeled probe for the FLT1P1 TaqMan assay were synthesized by Integrated DNA Technologies (Coralville, IA). A preformulated 18S ribosomal RNA assay (Hs99999901_s1; Applied Biosystems) was used as an endogenous reference. Expression of a gene or pseudogene relative to 18S rRNA was normalized and the fold difference of transcripts in treated samples relative to that in control samples was calculated using the ΔΔCT method.
+ Open protocol
+ Expand
3

Quantitative Analysis of Gene and miRNA Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA was isolated using the miRVana kit (Life technologies). The Maxima cDNA synthesis kit (Thermofisher Scientific) was used to generate cDNA and 2 µl cDNA was used for Taqman based quantitative real-time mRNA analysis containing 10 µl Taqman Fast Universal polymerase chain reaction (PCR) master mix (2×) no AmpErase UNG (Life Technologies), 1 µl Taqman primer probe (20×), in up to 20 µl nuclease-free water. GAPDH was used as the normalizer and one-way ANOVA was used to perform statistical analysis. Assay IDs were as follows: Hs01113624_g1 [TNFα], Hs00900055_m1 [VEGFA], Hs00985639_m1 [IL-6], Hs01028901_g1 [NFκB2] (Applied Biosystems, Carlsbad, CA). High capacity cDNA reverse transcription kit was used to generate cDNA for miRNAs. One microliter cDNA was used for Taqman based quantitative real-time mRNA analysis containing 5 µl Taqman Universal PCR master mix (2×) no AmpErase UNG (Life Technologies), 0.5 µl TaqMan microRNA assay (Assay ID 002182, Applied Biosystems), in up to 10 µl nuclease-free water. U6 snRNA (Assay ID 001973) for cellular or miR-223 (Assay ID 000526) for sEVs was used for normalization.
+ Open protocol
+ Expand
4

Evaluating anti-cancer therapies in NSCLC models

Check if the same lab product or an alternative is used in the 5 most similar protocols
RNA extraction, reverse transcription to cDNA and real-time quantitative PCR were performed as previously described [25] . The primers used were Hs00174265_m1 for APN/CD13, Hs00900055_m1 for vascular endothelial growth factor (VEGF) and 4352935E for β-actin (all from Applied Biosystems, Framingham, MA, USA).
Orthotopic implantation model EHMES-10 (3×10 6 ) or MSTO-211H (1×10 6 ) cells were injected into the thoracic cavity of SCID mice as previously described [23] and the mice were randomly assigned to control or drug treatment groups. MT95-4 (0.3 or 1 mg•kg -1 ) and control human IgG (Sigma-Aldrich, St Louis, MO, USA) were injected intraperitoneally twice weekly, and cisplatin (3 mg•kg -1 ) was injected i.p. once weekly. All mice were killed on day 28 (EHMES-10) or day 21 (MSTO-211H) after tumour cell inoculation, the thoracic tumours were carefully removed and weighed, and pleural effusions were harvested using a 1 mL syringe, followed by volumetric measurement.
+ Open protocol
+ Expand
5

Gene Expression Analysis of VEGFA and VEGFC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated from the cells using an RNeasy minikit (74104; Qiagen) and DNase treated with the RNase-free DNase set (79254; Qiagen). RNA was reverse transcribed with random primers using a RevertAid first-strand cDNA synthesis kit (K1621; Thermo Fisher Scientific). Expression analysis was achieved (by RT-qPCR) using a human VEGFA (Hs00900055_m1; Thermo Fisher Scientific) and human VEGFC (Hs01099203_m1; Thermo Fisher Scientific) TaqMan assay or specific primers for VEGFC-LNC (5′→3′, FW, CCAGGAGCCTCAAACTCTAATC; and RV, TGCTGCATCCTTGTCCTTAA) with the FastStart Universal SYBR green master (Rox) assay (4913914001; Merck). Gene expression was normalized to that of GAPDH or ACTB (4333764F and 4333762T, respectively; Applied Biosystems, Foster City, CA), and relative expression was calculated using the ΔΔCT method (where CT is threshold cycle) (118 (link)).
+ Open protocol
+ Expand
6

VEGF-A Expression Analysis in Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Purelink RNA Mini Kit (ThermoFisher Scientific) was used and the manufacturer's protocol was followed to extract total RNA from cell culture. Reverse transcription was performed using 1 µg of total RNA per 50 µL of reaction volume of TaqMan Reverse Transcription Reagents (ThermoFisher Scientific). Complementary DNA was obtained by incubating the reaction in thermal cycler (Veriti, Applied Biosystem, ThermoFisher Scientific). Real-time quantitative PCR was performed using TaqMan Fast Advanced Master Mix solution (ThermoFisher Scientific) and amplification was achieved using QuantStudio 6. GAPDH expression was used as an internal control. The probes included Hs00900055_m1 (ThermoFisher Scientific) for VEGF-A and Hs02758991_g1 (ThermoFisher Scientific) for GAPDH.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!